Bionano Genomics, Inc.
BNGO
Cena:
$ 1.24
+0.01 (0.81%)
Valuace
70
Růst
30
Zdraví
75
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 353.36 tis | 6.49% | -0.02% | 0.03% | 2025-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 167.53 tis | 3.08% | 0.00% | 0.00% | 2025-03-31 |
| VANGUARD GROUP INC | 82.31 tis | 1.54% | 0.00% | 0.00% | 2025-03-31 |
| CARRET ASSET MANAGEMENT, LLC | 70.00 tis | 1.29% | 0.00% | 0.01% | 2025-09-30 |
| VANGUARD FIDUCIARY TRUST CO | 51.58 tis | 0.95% | 0.00% | 0.00% | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 48.70 tis | 0.89% | 0.00% | 0.00% | 2025-12-31 |
| PRUDENTIAL FINANCIAL INC | 28.00 tis | 0.51% | 0.00% | 0.00% | 2026-03-31 |
| NORTHERN TRUST CORP | 20.52 tis | 0.38% | 0.00% | 0.00% | 2025-12-31 |
| TWO SIGMA SECURITIES, LLC | 18.06 tis | 0.33% | 0.00% | 0.00% | 2025-09-30 |
| VIRTU FINANCIAL LLC | 13.75 tis | 0.25% | 0.00% | 0.00% | 2026-03-31 |
| ENGINEERS GATE MANAGER LP | 11.85 tis | 0.22% | 0.00% | 0.00% | 2025-12-31 |
| BLACKROCK, INC. | 9.94 tis | 0.18% | 0.00% | 0.00% | 2025-03-31 |
| ADVISOR GROUP HOLDINGS, INC. | 6.80 tis | 0.12% | 0.00% | 0.00% | 2025-03-31 |
| GROUP ONE TRADING, L.P. | 0.96 tis | 0.02% | 0.00% | 0.00% | 2025-03-31 |
| MORGAN STANLEY | 0.93 tis | 0.02% | 0.00% | 0.00% | 2025-03-31 |
| SBI SECURITIES CO., LTD. | 0.23 tis | 0.00% | 0.00% | 0.00% | 2024-12-31 |
| VANGUARD GLOBAL ADVISERS, LLC | 0.17 tis | 0.00% | 0.00% | 0.00% | 2026-03-31 |
| WELLS FARGO & COMPANY/MN | 0.11 tis | 0.00% | 0.00% | 0.00% | 2025-03-31 |
| UBS GROUP AG | 0.02 tis | 0.00% | 0.00% | 0.00% | 2025-03-31 |
| BNP PARIBAS ARBITRAGE, SNC | 0.01 tis | 0.00% | 0.00% | 0.00% | 2025-03-31 |
| JPMORGAN CHASE & CO | 0.01 tis | 0.00% | 0.00% | 0.00% | 2025-03-31 |
| TD WATERHOUSE CANADA INC. | 0.01 tis | 0.00% | 0.00% | 0.00% | 2025-03-31 |
| ALLSQUARE WEALTH MANAGEMENT LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2024-12-31 |
| ALLWORTH FINANCIAL LP | 0.01 tis | 0.00% | 0.00% | 0.00% | 2025-03-31 |
| FMR LLC | 0.01 tis | 0.00% | 0.00% | 0.00% | 2026-03-31 |
| ACTIVEST WEALTH MANAGEMENT | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-03-31 |
| R SQUARED LTD | 0.00 tis | 0.00% | -0.01% | 0.00% | 2025-12-31 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-09-30 |
| PANDORA WEALTH, INC. | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-03-31 |
| WOLVERINE TRADING, LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2024-06-30 |
| NATIONAL BANK OF CANADA /FI/ | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-12-31 |
| RAYMOND JAMES FINANCIAL INC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-06-30 |
| WEALTHSPIRE ADVISORS, LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-09-30 |
| TWO SIGMA INVESTMENTS, LP | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-12-31 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-06-30 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-03-31 |
| XTX TOPCO LTD | 0.00 tis | 0.00% | 0.00% | 0.00% | 2024-12-31 |
| SUNBELT SECURITIES, INC. | 0.00 tis | 0.00% | 0.00% | 0.00% | 2024-12-31 |
| STIFEL FINANCIAL CORP | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-09-30 |
| STATE STREET CORP | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-09-30 |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2024-06-30 |
| SQUAREPOINT OPS LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2024-12-31 |
| RISE ADVISORS, LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-03-31 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-09-30 |
| MODUS ADVISORS, LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2024-12-31 |
| DLK INVESTMENT MANAGEMENT, LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2024-03-31 |
| CREDIT AGRICOLE S A | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-12-31 |
| CONCORD WEALTH PARTNERS | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-09-30 |
| COMPAGNIE LOMBARD ODIER SCMA | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-09-30 |
| COLDSTREAM CAPITAL MANAGEMENT INC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-03-31 |
| CLEAR STREET MARKETS LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-06-30 |
| CITIGROUP INC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2026-03-31 |
| CITADEL ADVISORS LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-09-30 |
| BANK OF AMERICA CORP /DE/ | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-03-31 |
| AVISO FINANCIAL INC. | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-03-31 |
| ATLANTIC UNION BANKSHARES CORP | 0.00 tis | 0.00% | 0.00% | 0.00% | 2026-03-31 |
| ARCHFORD CAPITAL STRATEGIES, LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-09-30 |
| ABOUND WEALTH MANAGEMENT | 0.00 tis | 0.00% | 0.00% | 0.00% | 2024-09-30 |
| DRW SECURITIES, LLC | 0.00 tis | 0.00% | -0.01% | 0.00% | 2025-12-31 |
| EVERSTAR ASSET MANAGEMENT, LLC | 0.00 tis | 0.00% | -0.46% | 0.00% | 2025-03-31 |
| MILLENNIUM MANAGEMENT LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-09-30 |
| JONES FINANCIAL COMPANIES LLLP | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-03-31 |
| JANE STREET GROUP, LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-12-31 |
| INSPIRE ADVISORS, LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-09-30 |
| HRT FINANCIAL LP | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-09-30 |
| GTS SECURITIES LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-09-30 |
| GPS WEALTH STRATEGIES GROUP, LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-03-31 |
| GOLDMAN SACHS GROUP INC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2024-12-31 |
| GOLDEN STATE EQUITY PARTNERS | 0.00 tis | 0.00% | 0.00% | 0.00% | 2024-06-30 |
| GMT CAPITAL CORP | 0.00 tis | 0.00% | -0.01% | 0.00% | 2023-09-30 |
| FIFTH THIRD BANCORP | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-03-31 |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-03-31 |
| FARTHER FINANCE ADVISORS, LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-03-31 |
| 0.00 tis | 0.00% | 0.00% | 0.00% | 2025-03-31 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| BARKER DAVID L | director | A-Award | 9149 | 1.19 | 14.5 2026 | 9149 |
| TWOMEY CHRISTOPHER J | director | A-Award | 9149 | 1.19 | 14.5 2026 | 9149 |
| Vuori Kristiina MD | director | A-Award | 9149 | 1.19 | 14.5 2026 | 9149 |
| Linney Yvonne | director | A-Award | 9149 | 1.19 | 14.5 2026 | 9149 |
| Rajkovic Aleksandar | director | A-Award | 9149 | 1.19 | 14.5 2026 | 9149 |
| Holmlin R. Erik | director, officer: PRESIDENT AND CEO | F-InKind | 51 | 1.10 | 18.2 2026 | 1657 |
| OLDAKOWSKI MARK | officer: CHIEF OPERATING OFFICER | F-InKind | 20 | 1.10 | 18.2 2026 | 895 |
| Dixon Jonathan V. | officer: GENERAL COUNSEL | F-InKind | 6 | 1.10 | 18.2 2026 | 263 |
| Adamchak Mark | officer: Principal Accounting Officer | F-InKind | 3 | 1.10 | 18.2 2026 | 260 |
| Chaubey Alka | officer: CHIEF MEDICAL OFFICER | F-InKind | 18 | 1.10 | 18.2 2026 | 644 |
| Holmlin R. Erik | director, officer: PRESIDENT AND CEO | A-Award | 69484 | 1.27 | 4.2 2026 | 69484 |
| Dixon Jonathan V. | officer: GENERAL COUNSEL | A-Award | 26117 | 1.27 | 4.2 2026 | 26117 |
| OLDAKOWSKI MARK | officer: CHIEF OPERATING OFFICER | A-Award | 27737 | 1.27 | 4.2 2026 | 27737 |
| Chaubey Alka | officer: CHIEF MEDICAL OFFICER | A-Award | 27737 | 1.27 | 4.2 2026 | 27737 |
| Adamchak Mark | officer: Principal Accounting Officer | A-Award | 10890 | 1.27 | 4.2 2026 | 10890 |
| Chaubey Alka | officer: Chief Medical Officer | F-InKind | 51 | 4.06 | 12.9 2025 | 662 |
| OLDAKOWSKI MARK | officer: Chief Operating Officer | F-InKind | 59 | 4.06 | 12.9 2025 | 915 |
| Rajkovic Aleksandar | director | A-Award | 2775 | 3.67 | 12.6 2025 | 2775 |
| Mamuszka Hannah | director | A-Award | 2775 | 3.67 | 12.6 2025 | 2775 |
| BARKER DAVID L | director | A-Award | 2775 | 3.67 | 12.6 2025 | 2775 |
| Luderer Albert | director | A-Award | 2775 | 3.67 | 12.6 2025 | 2775 |
| Linney Yvonne | director | A-Award | 2775 | 3.67 | 12.6 2025 | 2775 |
| Vuori Kristiina MD | director | A-Award | 2775 | 3.67 | 12.6 2025 | 2775 |
| TWOMEY CHRISTOPHER J | director | A-Award | 2775 | 3.67 | 12.6 2025 | 2775 |
| Dixon Jonathan V. | officer: General Counsel | F-InKind | 25 | 3.69 | 3.6 2025 | 269 |
| Holmlin R. Erik | director, officer: President and CEO | F-InKind | 75 | 3.69 | 3.6 2025 | 1708 |
| Chaubey Alka | officer: Chief Medical Officer | F-InKind | 24 | 3.69 | 3.6 2025 | 713 |
| Adamchak Mark | officer: Principal Accounting Officer | F-InKind | 7 | 3.69 | 3.6 2025 | 263 |
| OLDAKOWSKI MARK | officer: Chief Operating Officer | F-InKind | 27 | 3.69 | 3.6 2025 | 974 |
| Chaubey Alka | officer: Chief Medical Officer | A-Award | 6966 | 3.47 | 18.3 2025 | 6966 |
| OLDAKOWSKI MARK | officer: Chief Operating Officer | A-Award | 6966 | 3.47 | 18.3 2025 | 6966 |
| Holmlin R. Erik | director, officer: President and CEO | F-InKind | 198 | 3.47 | 18.3 2025 | 1783 |
| Holmlin R. Erik | director, officer: President and CEO | A-Award | 17449 | 3.47 | 18.3 2025 | 17449 |
| Adamchak Mark | officer: Principal Accounting Officer | A-Award | 3029 | 3.47 | 18.3 2025 | 3029 |
| Dixon Jonathan V. | officer: General Counsel | A-Award | 6559 | 3.47 | 18.3 2025 | 6559 |
| Adamchak Mark | officer: Principal Accounting Officer | F-InKind | 4 | 5.73 | 19.2 2025 | 270 |
| Chaubey Alka | officer: Chief Medical Officer | F-InKind | 18 | 5.73 | 19.2 2025 | 737 |
| Holmlin R. Erik | director, officer: President and CEO | F-InKind | 51 | 5.73 | 19.2 2025 | 1981 |
| Dixon Jonathan V. | officer: General Counsel | F-InKind | 6 | 5.73 | 19.2 2025 | 294 |
| OLDAKOWSKI MARK | officer: Chief Operating Officer | F-InKind | 20 | 5.73 | 19.2 2025 | 1001 |
| Adamchak Mark | officer: Principal Accounting Officer | A-Award | 17500 | 0.42 | 2.10 2024 | 17500 |
| Adamchak Mark | officer: Principal Accounting Officer | 17500 | 0.93 | 30.9 2024 | 0 | |
| Adamchak Mark | officer: Principal Accounting Officer | 6899 | 16.30 | 30.9 2024 | 0 | |
| Adamchak Mark | officer: Principal Accounting Officer | 8750 | 21.80 | 30.9 2024 | 0 | |
| Adamchak Mark | officer: Principal Accounting Officer | 4999 | 78.30 | 30.9 2024 | 0 | |
| Adamchak Mark | officer: Principal Accounting Officer | 753 | 10.40 | 30.9 2024 | 0 | |
| Adamchak Mark | officer: Principal Accounting Officer | 584 | 42.50 | 30.9 2024 | 0 | |
| Adamchak Mark | officer: Principal Accounting Officer | 1200 | 77.70 | 30.9 2024 | 0 | |
| Adamchak Mark | officer: Principal Accounting Officer | 0 | 0.00 | 30.9 2024 | 16471 | |
| Chaubey Alka | officer: Chief Medical Officer | F-InKind | 3075 | 0.48 | 13.9 2024 | 45323 |
| OLDAKOWSKI MARK | officer: Chief Operating Officer | F-InKind | 3568 | 0.48 | 13.9 2024 | 61283 |
| Linney Yvonne | director | A-Award | 30000 | 0.78 | 20.6 2024 | 30000 |
| TWOMEY CHRISTOPHER J | director | A-Award | 30000 | 0.78 | 20.6 2024 | 30000 |
| Mamuszka Hannah | director | A-Award | 30000 | 0.78 | 20.6 2024 | 30000 |
| Wong Vincent Jung-Fai | director | A-Award | 30000 | 0.78 | 20.6 2024 | 30000 |
| BARKER DAVID L | director | A-Award | 30000 | 0.78 | 20.6 2024 | 30000 |
| Vuori Kristiina MD | director | A-Award | 30000 | 0.78 | 20.6 2024 | 30000 |
| Luderer Albert | director | A-Award | 30000 | 0.78 | 20.6 2024 | 30000 |
| Rajkovic Aleksandar | director | A-Award | 30000 | 0.78 | 20.6 2024 | 30000 |
| Chaubey Alka | officer: CHIEF MEDICAL OFFICER | A-Award | 16000 | 0.00 | 5.6 2024 | 48245 |
| Chaubey Alka | officer: CHIEF MEDICAL OFFICER | A-Award | 75000 | 0.93 | 5.6 2024 | 75000 |
| Dixon Jonathan V. | officer: GENERAL COUNSEL | A-Award | 14500 | 0.00 | 5.6 2024 | 18025 |
| Dixon Jonathan V. | officer: GENERAL COUNSEL | A-Award | 68000 | 0.93 | 5.6 2024 | 68000 |
| Holmlin R. Erik | director, officer: PRESIDENT AND CEO | A-Award | 44000 | 0.00 | 5.6 2024 | 121813 |
| Holmlin R. Erik | director, officer: PRESIDENT AND CEO | A-Award | 204000 | 0.93 | 5.6 2024 | 204000 |
| Kama Gulsen | officer: Chief Financial Officer | A-Award | 16000 | 0.00 | 5.6 2024 | 16000 |
| Kama Gulsen | officer: Chief Financial Officer | A-Award | 75000 | 0.93 | 5.6 2024 | 75000 |
| OLDAKOWSKI MARK | officer: CHIEF OPERATING OFFICER | A-Award | 16000 | 0.00 | 5.6 2024 | 64698 |
| OLDAKOWSKI MARK | officer: CHIEF OPERATING OFFICER | A-Award | 75000 | 0.93 | 5.6 2024 | 75000 |
| Dixon Jonathan V. | officer: GENERAL COUNSEL | F-InKind | 402 | 1.27 | 5.3 2024 | 3525 |
| Holmlin R. Erik | director, officer: PRESIDENT AND CEO | F-InKind | 3073 | 1.27 | 5.3 2024 | 77663 |
| OLDAKOWSKI MARK | officer: CHIEF OPERATING OFFICER | F-InKind | 1229 | 1.27 | 5.3 2024 | 48644 |
| Chaubey Alka | officer: CHIEF MEDICAL OFFICER | F-InKind | 1081 | 1.27 | 5.3 2024 | 31487 |
| Kama Gulsen | officer: Chief Financial Officer | 0 | 0.00 | 20.9 2023 | 0 | |
| Kama Gulsen | officer: Chief Financial Officer | A-Award | 106000 | 3.00 | 20.9 2023 | 106000 |
| Chaubey Alka | officer: Chief Medical Officer | A-Award | 40000 | 3.00 | 20.9 2023 | 40000 |
| Chaubey Alka | officer: Chief Medical Officer | A-Award | 20000 | 0.00 | 20.9 2023 | 144794 |
| OLDAKOWSKI MARK | officer: Chief Operating Officer | A-Award | 40000 | 3.00 | 20.9 2023 | 40000 |
| OLDAKOWSKI MARK | officer: Chief Operating Officer | A-Award | 20000 | 0.00 | 20.9 2023 | 317842 |
| BARKER DAVID L | director | A-Award | 250000 | 0.75 | 16.6 2023 | 250000 |
| TWOMEY CHRISTOPHER J | director | A-Award | 250000 | 0.75 | 16.6 2023 | 250000 |
| Vuori Kristiina MD | director | A-Award | 250000 | 0.75 | 16.6 2023 | 250000 |
| Wong Vincent Jung-Fai | director | A-Award | 250000 | 0.75 | 16.6 2023 | 250000 |
| Linney Yvonne | director | A-Award | 250000 | 0.75 | 16.6 2023 | 250000 |
| Luderer Albert | director | A-Award | 250000 | 0.75 | 16.6 2023 | 250000 |
| Rajkovic Aleksandar | director | A-Award | 250000 | 0.75 | 16.6 2023 | 250000 |
| Mamuszka Hannah | director | A-Award | 250000 | 0.75 | 16.6 2023 | 250000 |
| Mamuszka Hannah | director | P-Purchase | 65789 | 0.76 | 14.6 2023 | 65789 |
| Holmlin R. Erik | director, officer: President and CEO | F-InKind | 50141 | 0.66 | 16.5 2023 | 791474 |
| OLDAKOWSKI MARK | officer: Chief Operating Officer | F-InKind | 41496 | 0.66 | 16.5 2023 | 297842 |
| Stewart Christopher P. | officer: Chief Financial Officer | P-Purchase | 50000 | 0.67 | 16.5 2023 | 281373 |
| Holmlin R. Erik | director, officer: President and CEO | P-Purchase | 15000 | 0.64 | 16.5 2023 | 806474 |
| Dixon Jonathan V. | officer: General Counsel | 117810 | 1.63 | 6.3 2023 | 0 | |
| Dixon Jonathan V. | officer: General Counsel | 350000 | 2.67 | 6.3 2023 | 0 | |
| Dixon Jonathan V. | officer: General Counsel | 0 | 0.00 | 6.3 2023 | 39270 | |
| Chaubey Alka | officer: Chief Medical Officer | A-Award | 560000 | 1.63 | 17.2 2023 | 560000 |
| OLDAKOWSKI MARK | officer: Chief Operating Officer | A-Award | 120000 | 0.00 | 17.2 2023 | 339338 |
| OLDAKOWSKI MARK | officer: Chief Operating Officer | A-Award | 560000 | 1.63 | 17.2 2023 | 560000 |
| Holmlin R. Erik | director, officer: President and CEO | A-Award | 300000 | 0.00 | 17.2 2023 | 841615 |
| Holmlin R. Erik | director, officer: President and CEO | A-Award | 1400000 | 1.63 | 17.2 2023 | 1400000 |
